Literature DB >> 9104800

IgE lambda monoclonal gammopathy and amyloidosis.

J M Jako1, T Gesztesi, I Kaszas.   

Abstract

The prevalence of IgE myeloma is 0.01% in all plasmocytomas. Although signs and symptoms are similar, it is generally accepted that IgE myeloma has a more malignant clinical course than other forms of plasmocytoma with monoclonal gammopathy. The disease has widely variable presentation. Most of the reported cases were accompanied by complications that are rarely seen with other types of myeloma. So far only one idiopathic (benign?) IgE monoclonal gammopathy has been reported. This case report is the first recorded IgE myeloma in Hungary with a rather unusual clinical presentation and diagnostic process. It is of particular interest that a monoclonal chain was detected in the urine of the patient several years prior to diagnosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9104800     DOI: 10.1159/000237490

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  An unusual case of IgE-multiple myeloma presenting with systemic amyloidosis 2 years after cervical plasmacytoma resection.

Authors:  Masao Hagihara; Jian Hua; Morihiro Inoue; Naohiko Michikawa
Journal:  Int J Hematol       Date:  2010-08-10       Impact factor: 2.490

2.  IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells.

Authors:  Niklas Kehl; Michael Kilian; Julius Michel; Tim R Wagner; Sebastian Uhrig; Alexander Brobeil; Lilli-Sophie Sester; Sven Blobner; Simon Steiger; Michael Hundemer; Niels Weinhold; Karsten Rippe; Stefan Fröhling; Stefan B Eichmüller; Lukas Bunse; Carsten Müller-Tidow; Hartmut Goldschmidt; Michael Platten; Marc-Steffen Raab; Mirco J Friedrich
Journal:  J Immunother Cancer       Date:  2022-10       Impact factor: 12.469

3.  Prozone effect of serum IgE levels in a case of plasma cell leukemia.

Authors:  Giampaolo Talamo; William Castellani; Nathan G Dolloff
Journal:  J Hematol Oncol       Date:  2010-09-10       Impact factor: 17.388

4.  IgE myeloma with elevated level of serum CA125.

Authors:  Man-Ling Wang; Qiang Huang; Tian-Xin Yang
Journal:  J Zhejiang Univ Sci B       Date:  2009-07       Impact factor: 3.066

5.  Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance.

Authors:  Masako Yasuyama; Toshie Ogasawara; Kuniaki Otsuka; Motohiko Aiba; Kiyotaka Kawauchi
Journal:  Hematol Rep       Date:  2012-07-02

6.  Hodgkin's lymphoma presenting with markedly elevated IgE: a case report.

Authors:  Anne K Ellis; Susan Waserman
Journal:  Allergy Asthma Clin Immunol       Date:  2009-12-07       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.